GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Flight Medical Innovations Ltd (XTAE:FLGM-M) » Definitions » Debt-to-EBITDA

Flight Medical Innovations (XTAE:FLGM-M) Debt-to-EBITDA : 0.00 (As of . 20)


View and export this data going back to . Start your Free Trial

What is Flight Medical Innovations Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Flight Medical Innovations's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₪0.00 Mil. Flight Medical Innovations's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₪0.00 Mil. Flight Medical Innovations's annualized EBITDA for the quarter that ended in . 20 was ₪0.00 Mil.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Flight Medical Innovations's Debt-to-EBITDA or its related term are showing as below:

XTAE:FLGM-M's Debt-to-EBITDA is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.48
* Ranked among companies with meaningful Debt-to-EBITDA only.

Flight Medical Innovations Debt-to-EBITDA Historical Data

The historical data trend for Flight Medical Innovations's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Flight Medical Innovations Debt-to-EBITDA Chart

Flight Medical Innovations Annual Data
Trend
Debt-to-EBITDA

Flight Medical Innovations Quarterly Data
Debt-to-EBITDA

Competitive Comparison of Flight Medical Innovations's Debt-to-EBITDA

For the Medical Devices subindustry, Flight Medical Innovations's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Flight Medical Innovations's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Flight Medical Innovations's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Flight Medical Innovations's Debt-to-EBITDA falls into.


;
;

Flight Medical Innovations Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Flight Medical Innovations's Debt-to-EBITDA for the fiscal year that ended in . 20 is calculated as

Flight Medical Innovations's annualized Debt-to-EBITDA for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (. 20) EBITDA data.


Flight Medical Innovations  (XTAE:FLGM-M) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Flight Medical Innovations Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Flight Medical Innovations's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Flight Medical Innovations Headlines

No Headlines